Wound Care Gopi Sir
Wound Care Gopi Sir
Wound Care Gopi Sir
Anatomy of Skin
Thickness varies from a thin membrane at internal flexures (e.g. elbows), to thicker at the soles of the feet which bear considerable pressures Hair follicles, sebaceous glands, and sweat glands pass through the epidermis, but arise from the dermal layer
Definition
A cut or break in the continuity of any tissue, caused by injury or operation
Classification of wounds
Partial Thickness
Involves the epidermis and the dermis
Full Thickness
Involves the epidermis, dermis, fat, fascia and exposes bone
According to contamination
Clean - (non traumatic) Clean contaminated Contaminated Dirty
According to Grading by tissue Involvement Grade I non-blanchable erythema of intact skin. Discoloration of the skin, warmth, oedema, induration or hardness may also be used as indicators in people with dark skin. Grade II partial-thickness skin loss involving epidermis, dermis or both.The ulcer is superficial and presents clinically as an abrasion or blister.
Grade III full thickness skin loss involving damage or necrosis of subcutaneous tissue that may extend down to but not through underlying fascia Grade IV extensive destruction, tissue necrosis or damage to muscle, bone or supporting structures with or without full thickness skin loss.
Wound healing
All wounds heal following a specific sequence of phases which may overlap The process of wound healing depends on the type of tissue which has been damaged and the nature of tissue disruption The phases are: Inflammatory phase Proliferative phase Remodelling or maturation phase
Granulation
Day 3 14 Characterised by the formation of granulation tissue in the wound Granulation tissue consists of a combination of cellular elements including: Fibroblasts, inflammatory cells, new capillaries embedded in a loose extra-cellular collagen matrix, fibronectin and hyularonic acid
Angiogenesis
Collagen first detected at day 3 and rapidly increases for approx. 3 weeks, then more gradually for the next 3 months Fibroplasia (fibroblast proliferation and synthetic activity) continues in parallel with re-vascularisation Endothelial cells from the side of venules closest to the wound begin to migrate in response to angiogenic stimuli (angiogenesis) forming capillary buds, then loops
Epithelialisation
The epidermis immediately adjacent to the wound edge begins to thicken within 24hrs after injury In approximated incised wounds reepithelialisation is usually complete within 48hrs.
Maturation
Can last up to 2 years New collagen forms, changing the shape of the wound and increasing the tensile strength Scar tissue, however is only ever approx. 5080% as strong as the original tissue During the remodelling process there is a gradual reduction in cellularity and vascularity of the reparative tissue
Contraction
Only undesirable where it leads to unacceptable tissue distortion and an unsatisfactory cosmetic result Wound contraction usually begins from day 5 and is complete at approx. day 12 - 15
There are clinical studies which have shown that wounds maintained in a moist environment have lower infection rates and heal more quickly
General Factors
Age Obesity Vitamin deficiency Anaemia Malignancy Uraemia Jaundice Diabetes, metabolic diseases HIV & immunosuppressive diseases Steroids & cytotoxic drugs Neuropathies of different causes
Practical considerations
The cause of the wound Underlying disease processes
Current health status
Healing requirements
Identification of the hindrance to healing Adequate nutritional status Adequate perfusion and oxygenation High quality, research-based patient and wound management Correction of the underlying cause of the problem Disease management
Wound assessment
Signs of infection
Lab tests: TcPO2
Odour or exudate
WOUND ASSESSMENT
Wound edge
granulation
Clinical appearance
Slough (yellow) Necrotic tissue (black) Infected tissue (green) Granulating tissue (red) Epithelialising (pink)
Sloughy wound
Aim: to liquefy slough and aid its removal Dead cells accumulated in exudate Prepare wound bed for granulation Assess wound depth and exudate levels Hydrogels, hydrocolloids, alginates and hydrofibre dressings
Necrotic wound
Aims: to debride and remove eschar Provide the right environment for autolysis Assess wound depth and exudate levels Hydrogels, hydrocolloid dressings
Infected wound
Aims: reduce exudate, odour and promote healing Clinical signs of infection Swab wound systemic antibiotics Treat symptomatically: exudate and odour control Change dressings daily
Granulating wound
Aims: support granulation, protect new tissue, keep moist Assess depth and exudate levels Moist wound surface non-adherent dressing Treat over-granulation Hydrocolloids, foams, alginates
Epithelialising wound
Aims: to provide
suitable conditions for re-surfacing , films, hydrocolloids Disturb as little as possible
Wound characteristics
Exudate Odour Condition of tissue within the wound Condition of the surrounding skin
The surrounding skin Eczema Psoriasis Maceration/excoriation due to exudate or bowel contents Self-inflicted damage
Dressing choice
The purpose of dressings: To aid debridement To remove excess exudate To control bleeding To protect a wound To support healing
Dressing choice
Non-adherent wound contact materials Films Hydrogels Hydrofibre dressings Hydrocolloids Foams Alginates Miscellaneous
Wound Cleansing
The aims of wound cleansing are to remove any foreign matter such as gravel or soil, to remove any loose surface debris such as necrotic tissue and remove any remnants of the previous dressing.
Traditional methods: Swabbing with cotton wool Antiseptic solution Dry dressings Daily change of dressing/wound inspection
Lotions and potions Hypochlorites Hydrogen peroxide Chlorhexidine Proflavine Saline 0.9%
Saline 0.9%
The only completely safe cleansing agent Safe to use with wound management products Sachets, plastic containers and aerosols for easy irrigation
Necrotic wounds
Aim: to debride and remove eschar Masks the full extent of the wound Provide the right environment for autolysis Assess wound depth and exudate levels Hydrogels, hydrocolloids, alginates, hydrofibre dressings
Sloughy wounds
Aim: to liquefy slough and aid its removal Dead cells accumulated in exudate Prepare wound bed for granulation Assess wound depth and exudate levels Hydrogels, hydrocolloids, alginates and hydrofibre dressings
Infected wounds Aim: reduce exudate, odour and promote healing Clinical signs of infection Swab wound systemic antibiotics Treat symptomatically: exudate and odour control Change dressings daily
Granulating wounds
Aim: support granulation, protect new tissue, keep moist Assess depth and exudate levels Moist wound surface non-adherent dressing Treat overgranulation Hydrocolloids, foams, alginates
Epithelialising wounds
Aims: to provide suitable conditions for re-surfacing N.A. ultra, films, hydrocolloids Disturb as little as possible
Film dressings
Semi-permeable primary or secondary dressings Clear polyurethane coated with adhesive Conformable, resistant to shear and tear Do not absorb exudate Examples: Tegaderm, Op-site.
Hydrocolloids
Pectin, gelatin, carboxymethylcellulose and elastomers Environment for autolysis to debride sloughy or necrotic wounds Occlusive --> hypoxic environment to encourage angiogenesis Waterproof Different presentations e.g. Urgotul
Foam dressings Advanced polymer technology Non-adherent wound contact layer Highly absorptive Semi-permeable Various types Adhesive and non-adhesive
Hydrogels
Sheets or gels Starch and polyacrylamide (94% water) Low exudate, shallow wounds Re-hydrates necrotic tissue Secondary dressing needed May cause skin maceration
Alginates
Seaweed dressings Form a gel over the wound Moderate to high exudate wounds Easily removed Can cause pain Help to debride a wound Different presentations
Tissue Viability
Documenting wound care Potential for litigation Good staff communication Continuity of care To assess progress or deterioration Should be factual not subjective Wound assessment charts
Patient assessment parameters Nutritional status Level of mobility Mental attitude (compliance) Dressing tolerance Age Metabolic disease Vascular insufficiency
Is the wound acute or chronic? Post-operative? Healing or non-healing? Underlying cause? Infected or colonised? Skin problems around the wound?
Assessment parameters
Cause Wound classification Depth of the wound Shape and size The amount of exudate The position of the wound The clinical appearance The environment of care
Biosurgery
(Larval therapy)
Lucilia sericata (greenbottles) Ingest bacteria which are destroyed in their gut Wide range of infected wounds Removes slough and malodour Bred as sterile larvae
2mm long special dressing technique Sleeves or bags Numbers needed Removal Reassessment
Associated problems Potentially infected larvae Allergic reaction Tickling sensation Ethical issues Aesthetic issues
VAC Therapy
Provides a moist environment Prevents bacterial activity Evacuates excess exudate Kills anaerobic bacteria in the wound bed Controls odour
Negative pressure suction drainage Not a new idea as surgeons have employed drainage
methods for years The difference: the application of topical negative subatmospheric pressure across the surface of the wound
Indications
Chronic non-healing wounds:
Dehisced surgical wounds Acute and traumatic wounds Meshed flaps and grafts Graft and flap donor sites
Others
Contraindications Fistula of unknown source Opening into a body cavity Vulnerable body organs (protect) Malignancy Necrotic tissue with eschar Untreated osteomyelitis
Recommended regime Negative pressure 50-75mmHg split-skin graft, leg ulcer 125mmHg all other wounds Cycle continuous for 48 hours then intermittent pressure wound assessment determines cycle Dressing changes 4-5 days (every 48 hours if infected)
Wound selection Type of foam dressing The degree of negative pressure The duration of treatment
Laser therapy
Little evidence of faster healing Needs expert handling May increase tensile strength Costly Time-consuming
Hydrofibre dressing
Aquacel hydrofibre, non-woven hydrocolloid dressing Forms a non-sticky gel Very absorbent Moist environment Needs secondary dressing
Urgotul hydrocolloid and petroleum jelly Promogran collagen and cellulose it interferes with substances (proteases) in the wound that prevent it healing
Natural skin
Vivoderm, Dermagraft, Apligraf Expensive but cost-effective Reduce need for skin grafts Useful for diabetic ulcers
Growth hormones Proteins that direct biological processes Chronic wound deficiency Messengers Under research
Hyaluronic acid Hyalofil promotes rapid healing Optimum environment Expensive Requires secondary dressing
Xelma
What is Xelma extracellular matrix protein? Xelma consists of amelogenin proteins, a thickening agent propylene glycol alginate (PGA) and water. Xelma has been proven to improve healing in hard to heal ulcers. What is Xelma for? Xelma is a medical device for treatment of hard-toheal ulcers, primarily venous leg ulcers. It is indicated for use with standard compression therapy of noninfected wounds.
Xelma
How is Xelma different from other therapies? Xelma is the first product containing extracellular matrix protein, amelogenin, which temporarily replaces the damaged extracellular matrix proteins in the hard-to-heal wounds in order to restore wound healing. How does Xelma work? When applied to the wound bed Xelma provides a temporary extracellular matrix protein for cell attachment. This creates favourable conditions for wound healing by restoring vital cell functions including proliferation, migration and production of growth factors and essential extracellular matrix proteins. Restoration of the cellular and biochemical balance is facilitated in the hard-to-heal wound, which will promote granulation tissue formation and normal wound healing.
MySkin
Myskin
is a cultured autologous epidermal substitute for the treatment of burns, ulcers and other non-healing wounds. Myskin contains living cells expanded from the tissue of individual patients. Each patient treated with Myskin receives only their own cells in a viable state designed to initiate wound closure. Myskin comprises a layer of keratinocytes (epidermal cells) on an advanced polymer-like coating which facilitates the transfer of cells into the wound where they can initiate healing. Myskin uses a medical grade silicone substrate layer to support cell delivery, wound coverage and allow exudate management.
Myskin
Myskin case studies Patient Profile Mrs B 68 years old Medical Condition Two chronic non-healing pressure ulcers. The Patient After receiving a burn to her leg Mrs B was left with scar tissue causing her foot to become deformed. Pressure ulcers developed from her corrective footwear and despite conventional treatment they remained unhealed for three years. Mrs B was also awaiting surgery to correct her foot which was not possible until the ulcers had healed.
Myskin
Evaluation Mrs B has undergone three skin grafts along with conventional treatment all of which have failed to heal the ulcers. Mrs B was then referred for treatment with Myskin. For Myskin treatment, a thin biopsy (approximately 0.6mm thick, 2cmx2cm) of skin is taken from the thigh area and transported to the laboratory in sterile saline solution. The biopsy is treated with a digestive enzyme overnight. The following day the keratinocytes are isolated from the dermal/epidermal junction, multiplied in cell culture and stored in liquid nitrogen until they are needed. Three days before dressings are required, keratinocytes are thawed and cultured on a 5cm silicone disc. These discs have a patented surface layer that encourages keratinocytes, to transfer from the dressing to the wound bed and promote re-epithelialization. This cell transfer process takes about four days after which the Myskin dressing can be removed and a standard dressing applied.
Myskin
Mrs B attended the clinic for the once weekly dressing applications which, after four days, were removed and replaced with a standard dressing. Twenty two weeks after the first Myskin dressing was applied one ulcer had healed completely and the second healed after forty five weeks. Both Ulcers Healed
Outcome After two applications Mrs B experienced a significant reduction in pain and once the ulcers had completely healed Mrs B was referred back to the orthopaedic team. She has since had her foot deformity corrected with no complications post operatively. Mrs B has now resumed activities which she previously enjoyed such as swimming and has been on holiday. Due to the severity, location and age of the ulcers it was necessary for Mrs B to have several more applications of myskin than usually required. It has been found that up to twelve applications are usually needed to heal a chronic wound although the number of applications may vary between patients.
ANTIBIOTICS
Indications
1.Contaminated wound 2.Areas of marginal viability 3.Wounds involving joints, open fractures 4.All human bite wounds 5.Most animal bite wounds 6.Generally, wounds > 12hr. old
SPECIAL WOUNDS
Bite Wounds High risk of infection with involvement of bones, joints, tendons, vessels, nerves Puncture wounds (difficult to irrigate and decontaminate)
Dog Bites 75% involve the extremities Most dog bites in children involve an extremity Severe facial lacerations involve the cheeks and lips as they try to "kiss the doggie
Closure
Dog bites scalp, face, trunk, proximal extremities may be closed if superficial never close primarily Human bites (delay 48 72hr.)
Puncture Wounds
Never close Irrigate drain, if necessary Foot shoe on or barefoot? Increased infection risk if shoe on
Abscesses Incise, drain, irrigate, loosely pack with Iodoform gauze Return at 24 hrs. for irrigation fresh pack Return at 48 hrs. for pack removal and healing by granulation
New onset DM may present with abscess Antibiotics may be indicated in addition to I&D
Nail / Nail Bed Injury Subungual hematoma, < 40 % nail area, nail bed injury unlikely, but distal phalanx fx. Might be present Treatment: Battery cautery to make drainage hole in nail, irrigate with 25ga. needle and 1% lidocaine Nail Bed - requires surgical repair
Foreign Bodies
Inert (glass, metal), may leave unremoved if necessary Organic (wood), must be removed
Vamana
Eix qx vT i MT e uvwi : | xYs vrq kU uh mcNSl Wiq || x c 1/31 Wound with hypergranulation,shotha having predominance of kapha, blackish or reddish wounds vamana is beneficial.
VIRECHANA
Wounds afflicted by Vata & predominance of Pitta Dosha Situated in Madhyama & Adhoshaka of the body Non healing wounds, chronic wounds
BASTI
Nirooha & Anuvasana - Vata dustha, Rooksha, Ati vedana. - Adha kayagata Vrana - Prepared with Tikta Rasa drugs
SIRAVYDHANA
Vrana which is predominant of Pitta and Rakta In Margavarana conditions,raktamokshana is advised Indicated in shothayuktha, kathina, shyama, aruna rakta and vedanayukta vrana with vishalamoola.
LEKHANA
Should be done in Kathina(hard), thick & rolled margins of vrana and in hard & raised granulated surface
KASHAYA
Kashaya should be used for shodhana, in wound having foul smell, Kledayukta, Picchila, Shodhana kashaya drugs are Shankhini, Ankhotha, Karaveera, Sumana, Suvarchala & Aragvadhadhi gana
VARTI
Varti should be used for shodhana, in wound where there is a foreign body, with narrow opening & deep seated.
KALKA
Kalka should be used for Shodhana in highly infected wound, foul smell, & when all the Doshas are involved (vata & kapha) Drugs are Haratala, Pippali, Maricha, Shunthi, Sphatika.
SARPI
In Pittaja Vrana symptoms are Daha & paka, the drug are used Karpasa Phala Siddha Ghrita
TAILA
In Kaphaja Vrana if wound is Utsanna Mamsa, Ruksha, Alpasravayukta the drugs to be used Sarshapa + Tila Taila
RASAKRIYA
An indurated ulcer, not responding to Taila should be purified with a dually prepared Rasakriya. Shodhana Rasakriya Brihati,Kantakari, Haritala, Manashila
AVACHOORNA
Medhayuktha, superficial wound, foul smell conditions choorna is used for Shodhana Drugs are Kaseesa, Saindava, Vacha, Rajanidwaya
Kasisa
PATRADANA Sthira, Alpamamsa, Roukshya, Anuparohatam. Pittaja & Raktaja vrana for Shaitya karanat Vataja & Kaphaja vrana for Oushnyam karanat KRIMIGHNA Surasadi gana, Karanja, Arka, Nimba etc for Dhavana & Poorana
Conclusion
Wound care is complex There are no easy solutions Evidence is needed of efficacy and cost-effectiveness Correction of the underlying causative factors is essential Key principles must be adhered to with regard to basic patient and wound assessment